Delivery Order SPE2DR25D3019-SPE2DR26FK4DF
- Not listed
- The Defense Logistics Agency awarded a $27,169.36 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on November 24, 2025, with completion targeted for November 25, 2025. This firm fixed price, non-set-aside delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $10,623.31 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $11,589.48 delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 4, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency has awarded a $12,054.16 delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency awarded a $50,619.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens. This non-set-aside contract was awarded on December 8, 2025, with an ultimate completion date of December 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical supply transaction under the company's larger contract vehicle...
- The Defense Logistics Agency awarded a $3,267.57 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 30, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to...
- The Defense Logistics Agency awarded a $36,275.25 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 9, 2025. This competitive award, issued on December 8, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,922.90 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This competitively awarded contract, issued on November 5, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order valued at $11,480.21 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion date of December 1, 2025. This non-set-aside, firm fixed-price delivery order was issued on November 28, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $12,072.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This non-competitive delivery order, which is set to be completed by November 18, 2025, represents a routine pharmaceutical procurement for the federal medical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Defense...
- SPE2DR25D3019Indefinite Delivery Contract
- SPE2DR25D3019-SPE2DR26FK4DFDelivery Order
The Defense Logistics Agency awarded a $16,924.96 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, with final delivery due by December 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, and the work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction under the company's existing contract vehicle with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems worldwide. Repatha is a PCSK9 inhibitor indicated for cardiovascular disease management, and its procurement through the federal supply chain reflects the Department of Defense's continued investment in preventive and specialty pharmaceuticals for service members and beneficiaries. The non-competitive award demonstrates AmerisourceBergen's established capability to deliver specialized pharmaceutical products within the federal procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.9k | 12/7/25 |